Showing 1 - 6 results of 6 for search 'Frederic Peyrade', query time: 0.03s Refine Results
  1. 1
    HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE? by Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré

    Published 2014-07-01
    Get full text
    Article
  2. 2
    Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation

    Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation by Frederic Peyrade, Daniel Re, Clemence Ginet, Lauris Gastaud, Maryline Allegra, Robert Ballotti, Antoine Thyss, Thorsten Zenz, Patrick Auberger, Guillaume Robert

    Published 2013-02-01
    Get full text
    Article
  3. 3
    Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

    Correction: Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for... by Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, Lucie Oberic, Olivier Chinot, Franck Morschhauser, Frédéric Peyrade, Roch Houot, Khê Hoang-Xuan, Hervé Ghesquieres, Carole Soussain

    Published 2024-10-01
    Get full text
    Article
  4. 4
    Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

    Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagn... by Marion Alcantara, Marion Chevrier, Fabrice Jardin, Anna Schmitt, Caroline Houillier, Lucie Oberic, Olivier Chinot, Franck Morschhauser, Frédéric Peyrade, Roch Houot, Khê Hoang-Xuan, Hervé Ghesquieres, Carole Soussain

    Published 2024-09-01
    Get full text
    Article
  5. 5
    Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies

    Central nervous system relapse in patients over 80 years with diffuse large B‐cell lymphoma: an analysis of two LYSA studies by Aurélie Cabannes‐Hamy, Frederic Peyrade, Fabrice Jardin, Jean‐François Emile, Vincent Delwail, Nicolas Mounier, Corinne Haioun, Aurore Perrot, Olivier Fitoussi, Diane Lara, Richard Delarue, Marc André, Fritz Offner, Hervé Ghesquières, Laurent Pascal, Carole Soussain, Julien Lazarovici, Jean‐Marc Schiano, Philippe Gaulard, Hervé Tilly, Catherine Thieblemont, the LYSA, the lymphoma study association

    Published 2018-03-01
    Get full text
    Article
  6. 6
    Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study

    Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study by Julien Lazarovici, Peggy Dartigues, Pauline Brice, Lucie Obéric, Isabelle Gaillard, Mathilde Hunault-Berger, Florence Broussais-Guillaumot, Emmanuel Gyan, Serge Bologna, Emmanuelle Nicolas-Virelizier, Mohamed Touati, Olivier Casasnovas, Richard Delarue, Frédérique Orsini-Piocelle, Aspasia Stamatoullas, Jean Gabarre, Luc-Matthieu Fornecker, Thomas Gastinne, Fréderic Peyrade, Virginie Roland, Emmanuel Bachy, Marc André, Nicolas Mounier, Christophe Fermé

    Published 2015-12-01
    Get full text
    Article

Search Tools: